Federal Register / Vol. 82, No. 166 / Tuesday, August 29, 2017 / Notices 41035 

1For the reasons explained in the third-party 

certification final rule (80 FR 74570 at 74578– 

74579, November 27, 2015), and for consistency 

with the implementing regulations for the thirdparty certification program in 21 CFR parts 1, 11, 

and 16, this notice uses the term ‘‘third-party 

certification body’’ rather than the term ‘‘third-party 

auditor’’ used in section 808(a)(3) of the FD&C Act. 

completed DFUF order) in your wire 

transfer. Without the PIN, your payment 

may not be applied to your facility and 

your registration may be delayed. 

The originating financial institution 

may charge a wire transfer fee. If the 

financial institution charges a wire 

transfer fee it is required that you add 

that amount to the payment to ensure 

that the invoice is paid in full. Use the 

following account information when 

sending a wire transfer: U.S. Dept. of 

Treasury, TREAS NYC, 33 Liberty St., 

New York, NY 10045, Acct. No. 

75060099, Routing No. 021030004, 

SWIFT: FRNYUS33, Beneficiary: FDA, 

8455 Colesville Rd., 14th Floor, Silver 

Spring, MD 20993–0002. If needed, 

FDA’s tax identification number is 53– 

0196965. 

C. Complete the Information Online To 

Update Your Establishment’s Annual 

Registration for FY 2018, or To Register 

a New Establishment for FY 2018 

Go to the Center for Devices and 

Radiological Health’s Web site at 

https://www.fda.gov/MedicalDevices/ 

DeviceRegulationandGuidance/Howto

MarketYourDevice/Registrationand

Listing/default.htm and click the 

‘‘Access Electronic Registration’’ link on 

the left side of the page. This opens up 

a new page with important information 

about the FDA Unified Registration and 

Listing System (FURLS). After reading 

this information, click on the ‘‘Access 

Electronic Registration’’ link in the 

middle of the page. This link takes you 

to an FDA Industry Systems page with 

tutorials that demonstrate how to create 

a new FURLS user account if your 

establishment did not create an account 

in FY 2017. Manufacturers of licensed 

biologics should register in the BER 

system at https://www.fda.gov/Biologics

BloodVaccines/GuidanceCompliance

RegulatoryInformation/Establishment

Registration/BloodEstablishment

Registration/default.htm. 

Enter your existing account ID and 

password to log into FURLS. From the 

FURLS/FDA Industry Systems menu, 

click on the Device Registration and 

Listing Module (DRLM) of FURLS 

button. New establishments will need to 

register and existing establishments will 

update their annual registration using 

choices on the DRLM menu. When you 

choose to register or update your annual 

registration, the system will prompt you 

through the entry of information about 

your establishment and your devices. If 

you have any problems with this 

process, email: reglist@cdrh.fda.gov or 

call 301–796–7400 for assistance. (Note: 

This email address and this telephone 

number are for assistance with 

establishment registration only; they are 

not to be used for questions related to 

other aspects of medical device user 

fees.) Problems with the BER system 

should be directed to https://

www.accessdata.fda.gov/scripts/email/ 

cber/bldregcontact.cfm or call 240–402– 

8360. 

D. Enter Your DFUF Order PIN and PCN 

After completing your annual or 

initial registration and device listing, 

you will be prompted to enter your 

DFUF order PIN and PCN, when 

applicable. This process does not apply 

to establishments engaged only in the 

manufacture, preparation, propagation, 

compounding, or processing of licensed 

biologic devices. CBER will send 

invoices for payment of the 

establishment registration fee to such 

establishments. 

Dated: August 24, 2017. 

Anna K. Abram, 

Deputy Commissioner for Policy, Planning, 

Legislation, and Analysis. 

[FR Doc. 2017–18378 Filed 8–28–17; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2016–N–4119] 

Food Safety Modernization Act ThirdParty Certification Program User Fee 

Rate for Fiscal Year 2018 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing the 

fiscal year (FY) 2018 annual fee rate for 

recognized accreditation bodies and 

accredited certification bodies, and the 

fee rate for accreditation bodies 

applying to be recognized in the thirdparty certification program that is 

authorized by the Federal Food, Drug, 

and Cosmetic Act (the FD&C Act), as 

amended by the FDA Food Safety 

Modernization Act (FSMA). 

FOR FURTHER INFORMATION CONTACT: 

Donald Prater, Office of Foods and 

Veterinary Medicine, Food and Drug 

Administration, 10903 New Hampshire 

Ave., Bldg. 1, Rm. 3234, Silver Spring, 

MD 20993, 301–348–3007. 

DATES: This fee is effective October 1, 

2017. 

SUPPLEMENTARY INFORMATION: 

I. Background 

Section 307 of FSMA, Accreditation 

of Third-Party Auditors, amended the 

FD&C Act to create a new provision, 

section 808, under the same name. 

Section 808 of the FD&C Act (21 U.S.C. 

384d) directs FDA to establish a 

program for accreditation of third-party 

certification bodies 1 conducting food 

safety audits and issuing food and 

facility certifications to eligible foreign 

entities (including registered foreign 

food facilities) that meet our applicable 

requirements. Under this provision, we 

established a system for FDA to 

recognize accreditation bodies to 

accredit certification bodies, except for 

limited circumstances in which we may 

directly accredit certification bodies to 

participate in the third-party 

certification program. 

Section 808(c)(8) of the FD&C Act 

directs FDA to establish a 

reimbursement (user fee) program by 

which we assess fees and require 

reimbursement for the work FDA 

performs to establish and administer the 

third-party certification program under 

section 808 of the FD&C Act. The user 

fee program for the third-party 

certification program was established by 

a final rule entitled ‘‘Amendments to 

Accreditation of Third-Party 

Certification Bodies to Conduct Food 

Safety Audits and To Issue 

Certifications to Provide for the User 

Fee Program’’ (81 FR 90186, December 

14, 2016). 

The FSMA FY 2018 third-party 

certification program user fee rate 

announced in this notice is effective on 

October 1, 2017, and will remain in 

effect through September 30, 2018. 

II. Estimating the Average Cost of a 

Supported Direct FDA Work Hour for 

FY 2018 

In each year, the costs of salary (or 

personnel compensation) and benefits 

for FDA employees account for between 

50 and 60 percent of the funds available 

to, and used by, FDA. Almost all of the 

remaining funds (operating funds) 

available to FDA are used to support 

FDA employees for paying rent, travel, 

utility, information technology, and 

other operating costs. 

A. Estimating the Full Cost per Direct 

Work Hour in FY 2018 

Full-time Equivalent (FTE) reflects the 

total number of regular straight-time 

hours—not including overtime or 

holiday hours—worked by employees, 


sradovich on DSK3GMQ082PROD with NOTICES
41036 Federal Register / Vol. 82, No. 166 / Tuesday, August 29, 2017 / Notices 

divided by the number of compensable 

hours applicable to each fiscal year. 

Annual leave, sick leave, compensatory 

time off, and other approved leave 

categories are considered ‘‘hours 

worked’’ for purposes of defining FTE 

employment. 

In general, the starting point for 

estimating the full cost per direct work 

hour is to estimate the cost of an FTE 

or paid staff year. Calculating an 

Agency-wide total cost per FTE requires 

three primary cost elements: Payroll, 

non-payroll, and rent. 

We have used an average of past year 

cost elements to predict the FY 2018 

cost. The FY 2018 FDA-wide average 

cost for payroll (salaries and benefits) is 

$154,638; non-payroll—including 

equipment, supplies, IT, general and 

administrative overhead—is $89,224; 

and rent, including cost allocation 

analysis and adjustments for other rent 

and rent-related costs, is $23,922 per 

paid staff year, excluding travel costs. 

Summing the average cost of an FTE 

for payroll, non-payroll, and rent, brings 

the FY 2018 average fully supported 

cost to $267,783 per FTE, excluding 

travel costs. FDA will use this base unit 

fee in determining the hourly fee rate for 

third party certification user fees for FY 

2018 prior to including travel costs as 

applicable for the activity. 

To calculate an hourly rate, FDA must 

divide the FY 2018 average fully 

supported cost of $267,783 per FTE by 

the average number of supported direct 

FDA work hours in FY 2016—the last 

FY for which data are available. See 

table 1. 

TABLE 1—SUPPORTED DIRECT FDA 

WORK HOURS IN A PAID STAFF

YEAR IN FY 2016 

Total Number of Hours in a Paid 

Staff Year .................................. 2,080 

Less: 

10 paid holidays .................... ¥80 

20 days of annual leave ........ ¥160 

10 days of sick leave ............ ¥80 

12.5 days of training .............. ¥100 

26.5 days of general administration ................................. ¥184 

26.5 days of travel ................. ¥212 

2 hours of meetings per week ¥104 

Net Supported Direct 

FDA Work Hours 

Available for Assignments .......................... =1,160 

Dividing the average fully supported 

FTE cost in FY 2018 ($267,783) by the 

total number of supported direct work 

hours available for assignment in FY 

2016 (1,160) results in an average fully 

supported cost of $231 (rounded to the 

nearest dollar), excluding travel costs, 

per supported direct work hour in FY 

2018. 

B. Adjusting FY 2016 Travel Costs for 

Inflation To Estimate FY 2018 Travel 

Costs 

To adjust the hourly rate for FY 2018, 

FDA must estimate the cost of inflation 

in each year for FY 2017 and FY 2018. 

FDA uses the method prescribed for 

estimating inflationary costs under the 

Prescription Drug User Fee Act 

(PDUFA) provisions of the FD&C Act 

(section 736(c)(1) (21 U.S.C. 379h(c)(1)), 

the statutory method for inflation 

adjustment in the FD&C Act that FDA 

has used consistently. FDA previously 

determined the FY 2017 inflation rate to 

be 1.5468 percent; this rate was 

published in the FY2017 PDUFA user 

fee rates notice in the Federal Register. 

Utilizing the method set forth in section 

736(c)(1) of the FD&C Act, FDA has 

calculated an inflation rate of 1.5468 

percent for FY 2017 and 1.6868 percent 

for FY 2018 and FDA intends to use this 

inflation rate to make inflation 

adjustments for FY 2018 for several of 

its user fee programs; the derivation of 

this rate will be published in the 

Federal Register in the FY 2018 notice 

for the PDUFA user fee rates. The 

compounded inflation rate for FYs 2017 

and 2018, therefore, is 1.032597 (or 

3.2597 percent) (1 plus 1.5468 percent 

times 1 plus 1.6868 percent). 

The average fully supported cost per 

supported direct FDA work hour, 

excluding travel costs, of $231 already 

takes into account inflation as the 

calculation above is based on FY 2018 

predicted costs. FDA will use this base 

unit fee in determining the hourly fee 

rate for third-party certification program 

fees for FY 2018 prior to including 

travel costs as applicable for the 

activity. For the purpose of estimating 

the fee, we are using the travel cost rate 

for foreign travel because we anticipate 

that the vast majority of onsite 

assessments made by FDA under this 

program will require foreign travel. In 

FY 2016, the Office of Regulatory Affairs 

spent a total of $2,166,592 on 344.31 

foreign inspection trips related to FDA’s 

Center for Food Safety and Applied 

Nutrition and Center for Veterinary 

Medicine field activities programs, 

which averaged a total of $6,293 per 

foreign inspection trip. These trips 

averaged 3 weeks (or 120 paid hours) 

per trip. Dividing $6,293 per trip by 120 

hours per trip results in a total and an 

additional cost of $52 (rounded to the 

nearest dollar) per paid hour spent for 

foreign inspection travel costs in FY 

2016. To adjust $52 for inflationary 

increases in FY 2017 and FY 2018, FDA 

must multiply it by the same inflation 

factor mentioned previously in this 

document (1.032597 or 3.2597 percent), 

which results in an estimated cost of 

$54 (rounded to the nearest dollar) per 

paid hour in addition to $231 for a total 

of $285 per paid hour ($231 plus $54) 

for each direct hour of work requiring 

foreign inspection travel. FDA will use 

these rates in charging fees in FY 2018 

when travel is required for the thirdparty certification program. 

TABLE 2—FSMA FEE SCHEDULE FOR

FY 2018 

Fee category Fee rates for 

FY 2018 

Hourly rate without travel ..... $231 

Hourly rate if travel is required ................................ 285 

III. Fees for Accreditation Bodies and 

Certification Bodies in the Third-Party 

Certification Program Under Section 

808(c)(8) of the FD&C Act 

The third-party certification program 

assesses application fees and annual 

fees. In FY18, the only fees that will be 

collected by FDA under section 

808(c)(8) of the FD&C Act are the initial 

application fee for accreditation bodies 

seeking recognition, the annual fee for 

recognized accreditation bodies, and the 

annual fee for certification bodies 

accredited by a recognized accreditation 

body. Table 3 provides an overview of 

the fees for FY 2018. 

TABLE 3—FSMA THIRD-PARTY CERTIFICATION PROGRAM USER FEE

SCHEDULE FOR FY 2018 

Fee category Fee rates for 

FY 2018 

Initial Application Fee for Accreditation Body Seeking 

Recognition ....................... $37,935 

Annual Fee for Recognized 

Accreditation Body ............ 1,752 

Annual Fee for Accredited 

Certification Body .............. 2,190 

A. Application Fee for Accreditation 

Bodies Applying for Recognition in the 

Third-Party Certification Program Under 

Section 808(c)(8) of the FD&C Act 

Section 1.705(a)(1) (21 CFR 

1.705(a)(1)) establishes an application 

fee for accreditation bodies applying for 

initial recognition that represents the 

estimated average cost of the work FDA 

performs in reviewing and evaluating 

initial applications for recognition of 

accreditation bodies. 

The fee is based on the fully 

supported FTE hourly rates and 

estimates of the number of hours it 


sradovich on DSK3GMQ082PROD with NOTICES
Federal Register / Vol. 82, No. 166 / Tuesday, August 29, 2017 / Notices 41037 

would take FDA to perform relevant 

activities. These estimates represent 

FDA’s current thinking, and as the 

program evolves, FDA will reconsider 

the estimated hours. We estimate that it 

would take, on average, 60 person-hours 

to review an accreditation body’s 

submitted application, 48 person-hours 

for an onsite performance evaluation of 

the applicant (including travel and other 

steps necessary for a fully supported 

FTE to complete an onsite assessment), 

and 45 person-hours to prepare a 

written report documenting the onsite 

assessment. 

FDA employees are likely to review 

applications and prepare reports from 

their worksites, so we use the fully 

supported FTE hourly rate excluding 

travel, $231/hour, to calculate the 

portion of the user fee attributable to 

those activities: $231/hour × (60 hours 

+ 45 hours) = $24,255. FDA employees 

will likely travel to foreign countries for 

the onsite performance evaluations 

because most accreditation bodies are 

located in foreign countries. For this 

portion of the fee we use the fully 

supported FTE hourly rate for work 

requiring travel, $285/hour, to calculate 

the portion of the user fee attributable 

to those activities: $285/hour × 48 hours 

(i.e., 2 fully supported FTEs × (2 travel 

days + 1 day onsite)) = $13,680. The 

estimated average cost of the work FDA 

performs in total for reviewing an initial 

application for recognition for an 

accreditation body based on these 

figures would be $24,255 + $13,680 = 

$37,935. Therefore the application fee 

for accreditation bodies applying for 

recognition in FY 2018 will be $37,935. 

B. Annual Fee for Accreditation Bodies 

Participating in the Third-Party 

Certification Program Under Section 

808(c)(8) of the FD&C Act 

To calculate the annual fee for each 

recognized accreditation body, FDA 

takes the estimated average cost of work 

FDA performs to monitor performance 

of a single recognized accreditation 

body and annualizes that over the 

average term of recognition. At this time 

we assume an average term of 

recognition of 5 years. We also assume 

that FDA will monitor 10 percent of 

recognized accreditation bodies onsite. 

As the program proceeds, we will adjust 

the term of recognition as appropriate. 

We estimate that for one performance 

evaluation of a recognized accreditation 

body, it would take, on average (taking 

into account that not all recognized 

accreditation bodies would be 

monitored onsite), 24 hours for FDA to 

conduct records review, 8 hours to 

prepare a report detailing the records 

review and onsite performance 

evaluation, and 4.8 hours of onsite 

performance evaluation (i.e., 10 percent 

× 2 fully supported FTEs × (2 travel days 

+ 2 day onsite)). Using the fully 

supported FTE hourly rates in table 2, 

the estimated average cost of the work 

FDA performs to monitor performance 

of a single recognized accreditation 

body would be $7,392 ($231/hour × (24 

hours + 8 hours)) plus $1,368 ($285/ 

hour × 4.8 hours), which is $8,760. 

Annualizing this amount over 5 years 

would lead to an annual fee for 

recognized accreditation bodies of 

$1,752 for FY 2018. 

C. Annual Fee for Certification Bodies 

Accredited by a Recognized 

Accreditation Body in the Third-Party 

Certification Program Under Section 

808(c)(8) of the FD&C Act 

To calculate the annual fee for a 

certification body accredited by a 

recognized accreditation body, FDA 

takes the estimated average cost of work 

FDA performs to monitor performance 

of a single certification body accredited 

by a recognized accreditation body and 

annualizes that over the average term of 

accreditation. At this time we assume an 

average term of accreditation of 4 years. 

This fee is based on the fully supported 

FTE hourly rates and estimates of the 

number of hours it would take FDA to 

perform relevant activities. We estimate 

that FDA would conduct, on average, 

the same activities, for the same amount 

of time to monitor certification bodies 

accredited by a recognized accreditation 

body as we would to monitor an 

accreditation body recognized by FDA. 

Using the fully supported FTE hourly 

rates in table 2, the estimated average 

cost of the work FDA performs to 

monitor performance of a single 

accredited certification body would be 

$7,392 ($231/hour × (24 hours + 8 

hours)) plus $1,368 ($285/hour × 4.8 

hours), which is $8,760. Annualizing 

this amount over 4 years would lead to 

an annual fee for accredited certification 

bodies of $2,190 for FY 2018. 

IV. Estimated Fees for Accreditation 

Bodies and Certification Bodies in 

Other Fee Categories for FY 2018 

Section 1.705(a) also establishes 

application fees for recognized 

accreditation bodies submitting renewal 

applications, certification bodies 

applying for direct accreditation, and 

certification bodies applying for renewal 

of direct accreditation. Section 1.705(b) 

establishes annual fees for recognized 

accreditation bodies, certification bodies 

directly accredited by FDA, and 

certification bodies accredited by 

recognized accreditation bodies. 

Although we will not be collecting all 

of these other fees in FY 2018, for 

transparency and planning purposes, we 

have provided an estimate of what these 

fees would be for FY 2018 based on the 

fully supported FTE hourly rates for FY 

2018 and estimates of the number of 

hours it would take FDA to perform 

relevant activities as outlined in the 

Final Regulatory Impact Analysis for the 

Third-Party Certification Regulation. 

Table 4 provides an overview of the 

estimated fees for other fee categories. 

TABLE 4—ESTIMATED FEE RATES FOR

OTHER FEE CATEGORIES UNDER

THE FSMA THIRD-PARTY CERTIFICATION PROGRAM

Fee category 

Estimated fee 

rates for FY 

2018 

Renewal application fee for 

recognized accreditation 

body .................................. $21,049 

Initial application fee for certification body seeking direct-accreditation from 

FDA ................................... 37,935 

Renewal application fee for 

directly-accredited certification body ........................ 28,755 

Annual fee for certification 

body directly-accredited by 

FDA ................................... 21,072 

V. How must the fee be paid? 

Accreditation bodies seeking initial 

recognition must submit the application 

fee with the application. 

For recognized accreditation bodies 

and accredited certification bodies, an 

invoice will be sent annually. Payment 

must be made within 30 days of the 

invoice date. Detailed payment 

information will be included with the 

invoice when it is issued. 

VI. What are the consequences of not 

paying this fee? 

The consequences of not paying these 

fees are outlined in § 1.725. If FDA does 

not receive an application fee with an 

application for recognition, the 

application will be considered 

incomplete and FDA will not review the 

application. If a recognized 

accreditation body fails to submit its 

annual user fee within 30 days of the 

due date, we will suspend its 

recognition. If the recognized 

accreditation body fails to submit its 

annual user fee within 90 days of the 

due date, we will revoke its recognition. 

If an accredited certification body fails 

to pay its annual fee within 30 days of 

the due date, we will suspend its 

accreditation. If the accredited 

certification body fails to pay its annual 


sradovich on DSK3GMQ082PROD with NOTICES
41038 Federal Register / Vol. 82, No. 166 / Tuesday, August 29, 2017 / Notices 

fee within 90 days of the due date, we 

will withdraw its accreditation. 

Dated: August 23, 2017. 

Anna K. Abram, 

Deputy Commissioner for Policy, Planning, 

Legislation, and Analysis. 

[FR Doc. 2017–18222 Filed 8–28–17; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Director, National 

Institutes of Health: Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the Advisory Committee to 

the Director, National Institutes of 

Health. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Advisory Committee 

to the Director, National Institutes of Health. 

Date: September 14, 2017. 

Time: 2:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Building 1, One Center Drive, Bethesda, MD 

20892 (Telephone Conference Call). 

Contact Person: Gretchen Wood, Staff 

Assistant, National Institutes of Health, 

Office of the Director, One Center Drive, 

Building 1, Room 126, Bethesda, MD 20892, 

301–496–4272, Woodgs@od.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.14, Intramural Research 

Training Award; 93.22, Clinical Research 

Loan Repayment Program for Individuals 

from Disadvantaged Backgrounds; 93.232, 

Loan Repayment Program for Research 

Generally; 93.39, Academic Research 

Enhancement Award; 93.936, NIH Acquired 

Immunodeficiency Syndrome Research Loan 

Repayment Program; 93.187, Undergraduate 

Scholarship Program for Individuals from 

Disadvantaged Backgrounds, National 

Institutes of Health, HHS) 

Dated: August 24, 2017. 

Anna Snouffer, 

Deputy Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–18339 Filed 8–28–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Cancer Institute 

Council of Research Advocates. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. The open 

session will be videocast and can be 

accessed from the NIH Videocasting and 

Podcasting Web site (http://

videocast.nih.gov). 

Name of Committee: National Cancer 

Institute Council of Research Advocates. 

Date: September 25, 2017. 

Time: 9:00 a.m. to 4:30 p.m. 

Agenda: Welcome and Chairman’s 

Remarks, NCI Updates and Legislative 

Update. 

Place: National Institutes of Health, 40 

Convent Drive, Building 40, Conference 

Rooms 1201/1203, Bethesda, MD 20892. 

Contact Person: Amy Williams, NCI Office 

of Advocacy Relations National Cancer 

Institute, NIH, 31 Center Drive, Building 31, 

Room 10A28, Bethesda, MD 20892, 240–781– 

3406 williaam@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. Information is also available on the 

Institute’s/Center’s home page: NCRA: http:// 

deainfo.nci.nih.gov/advisory/ncra/ncra.htm, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: August 24, 2017. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–18343 Filed 8–28–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Coast Guard 

[Docket No. USCG–2017–0690] 

Cooperative Research and 

Development Agreement: 

Environmentally Friendly Buoy 

Mooring System 

AGENCY: Coast Guard, DHS. 

ACTION: Notice of intent; request for 

comments. 

SUMMARY: The Coast Guard is 

announcing its intent to enter into a 

Cooperative Research and Development 

Agreement (CRADA) with American 

Underwater Contractors, Inc. (AUC) to 

develop, demonstrate, evaluate and 

document the use of environmentally 

friendly buoy mooring systems (line and 

anchor) attached to a navigational buoy 

to determine the feasibility and 

practicality of the Coast Guard using 

both helix (screw) anchors and elastic 

mooring lines in environmentally 

sensitive areas. While the Coast Guard 

is currently considering partnering with 

AUC, we are soliciting public comment 

on the possible nature of and 

participation of other parties in the 

proposed CRADA. In addition, the Coast 

Guard also invites other potential nonFederal participants, who have the 

interest and capability to bring similar 

contributions to this type of research, to 

consider submitting proposals for 

consideration in similar CRADAs. 

DATES: Comments must be submitted to 

the online docket via http://

www.regulations.gov, or reach the 

Docket Management Facility, on or 

before September 27, 2017. 

Synopses of proposals regarding 

future CRADAs must reach the Coast 

Guard (see FOR FURTHER INFORMATION

CONTACT) on or before September 27, 

2017. 

ADDRESSES: Submit comments online at 

http://www.regulations.gov following 

Web site instructions. 


sradovich on DSK3GMQ082PROD with NOTICES